Clinical Trials in Nashville

Showing 1861-1880 of 17,403 trials

Integrative Approaches for Cancer Survivorship (IACS3)

NCT06633926

This clinical trial is a two-arm pilot randomized controlled trial for non-metastatic breast cancer survivors to determine the feasibility, acceptability, and fidelity of two integrative health approaches and study design in a multi-site setting. Participants (n=104) will be randomized to either the Ayurveda Intervention (AVI) or Facing Forward Health Education Intervention (FFHEI). Integrative health combines biomedical and complementary approaches together in a coordinated way. AVI, a multi-modal intervention, includes nutritional education, lifestyle practices, yoga, and therapeutic touch, called marma, to help the body and mind feel balanced. FFHEI provides health education using self-directed online content and interactive videos based on the latest science in cancer survivorship. This study does not intend to conduct tests of efficacy and is focused on feasibility outcomes.

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8

University of California, San Francisco108 participantsStarted Mar 2025

San Francisco, California, United States • San Francisco, California, United States • San Francisco, California, United States +1 more locations

Active Not RecruitingNA< 1 mile

Eliminating Monitor Overuse Trial (EMO Trial)

NCT05132322

The purpose of this study is to identify the optimal deimplementation strategies for an overused practice: continuous pulse oximetry monitoring of children hospitalized with bronchiolitis who are not receiving supplemental oxygen.

Bronchiolitis Acute Viral

Children's Hospital of Philadelphia9,265 participantsStarted Dec 2021

Birmingham, Alabama, United States • Davis, California, United States • Encinitas, California, United States +48 more locations

Integrative Approaches for Cancer Survivorship (IACS3)

Eliminating Monitor Overuse Trial (EMO Trial)

Find Trials by Condition in Nashville

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis

Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Safety and Immunogenicity of NVX-CoV2705

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Study of Bitopertin in Participants With EPP or XLP (APOLLO)

Observational Study of LUMRYZ in Narcolepsy

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Safety, Pharmacokinetics (PK), and Efficacy of ONC-783 in Advanced Solid Tumors